The Type I Interferon-α Mediates a More Severe Neurological Disease in the Absence of the Canonical Signaling Molecule Interferon Regulatory Factor 9
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Type I interferons (IFN) are crucial in host defense but also are implicated as causative factors for neurological disease. Interferon regulatory factor (IRF9) is involved in type I IFN-regulated gene expression where it associates with STAT1:STAT2 heterodimers to form the transcriptional complex ISGF3. The role of IRF9 in cellular responses to type I IFN is poorly defined in vivo and hence was examined here. While transgenic mice (termed GIFN) with chronic production of low levels of IFN-α in the CNS were relatively unaffected, the same animals lacking IRF9 [GIFNxIRF9 knock-out(KO)] had cataracts, became moribund, and died prematurely. The brain of GIFNxIRF9 KO mice showed calcification with pronounced inflammation and neurodegeneration whereas inflammation and retinal degeneration affected the eyes. In addition, IFN-γ-like gene expression in the CNS in association with IFN-γ mRNA and increased phosphotyrosine-STAT1 suggested a role for IFN-γ. However,GIFNxIRF9 KO mice deficient for IFN-γ signaling developed an even more severe and accelerated disease, indicating that IFN-γ was protective. In IRF9-deficient cultured mixed glial cells, IFN-α induced prolonged activation of STAT1 and STAT2 and induced the expression of IFN-γ-like genes. We conclude that (1) type I IFN signaling and cellular responses can occur in vivo in the absence of IRF9, (2) IRF9 protects against the pathophysiological actions of type I IFN in the CNS, and (3) STAT1 and possibly STAT2 participate in alternative IRF9-independent signaling pathways activated by IFN-α in glial cells resulting in enhanced IFN-γ-like responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meraz, M. A., White, J. M., Sheehan, K. C. F., Bach, E. A., Rodig, S. J., Dighe, A. S., Kaplan, D. H., Riley, J. K., Greenlund, A. C., Campbell, D., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81288-x · Cited by 1,656
Complex modulation of cell type-specific signaling in response to type I interferons
van Boxel-Dezaire, A. H. H., Rani, M. R. S., & Stark, G. R. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.014 · Cited by 530 · cited 1×
“Nevertheless, there is evidence for the existence of ISGF3-independent signal transduction pathways that are activated in the cellular response to type I IFNs (for review, see van Boxel-Dezaire et al., 2006).”
BackgroundGAS Elements: A Few Nucleotides with a Major Impact on Cytokine-Induced Gene Expression
DECKER, T., KOVARIK, P., & MEINKE, A. (1997) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1997.17.121 · Cited by 437
Haque, S. J., & Williams, B. R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32200-7 · Cited by 77
Cited by
Human TBK1: A Gatekeeper of Neuroinflammation
Ahmad, L., Zhang, S.-Y., Casanova, J.-L., & Sancho-Shimizu, V. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.04.006 · Cited by 208
Activation of interferon signaling pathways in spinal cord astrocytes from an ALS mouse model
Wang, R., Yang, B., & Zhang, D. (2011) · Glia · doi:10.1002/glia.21167 · Cited by 115
Type I interferon in neurological disease—The devil from within
Hofer, M. J., & Campbell, I. L. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.03.006 · Cited by 50
“molecules, STAT1 [153], STAT2 [154] or IRF9 [155] greatly exacerbates the neurological disease in GFAP-IFNa mice.”
BackgroundInfluentialSelf-citationPost-COVID-19 Parkinsonism and Parkinson’s Disease Pathogenesis: The Exosomal Cargo Hypothesis
Mysiris, D. S., Vavougios, G. D., Karamichali, E., Papoutsopoulou, S., Stavrou, V. T., Papayianni, E., Boutlas, S., Mavridis, T., Foka, P., Zarogiannis, S. G., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179739 · Cited by 25
“IRF9 had been previously identified as a protective functional protein in CNS homeostasis, and its absence could result in severe neurological damage in glial cultured cells due to interferon (IFN)α-mediated overexpression of IFN-γ-like genes [305].”
Background
Metadata
- Authors
- Hofer, M. J., Li, W., Lim, S. L., & Campbell, I. L.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2010-01-20
- Volume
- 30
- Issue
- 3
- Pages
- 1149-1157
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2042857056
- Cited by
- 31
- References
- 4
- FWCI
- 0.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Type I Interferon-α Mediates a More Severe Neurological Disease in the Absence of the Canonical Signaling Molecule Interferon Regulatory Factor 9. https://app.cochat.ai/papers/10.1523/jneurosci.3711-09.2010
- The paper
- Hofer, M. J., Li, W., Lim, S. L., & Campbell, I. L. (2010). The Type I Interferon-α Mediates a More Severe Neurological Disease in the Absence of the Canonical Signaling Molecule Interferon Regulatory Factor 9. The Journal of Neuroscience. https://doi.org/10.1523/jneurosci.3711-09.2010
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.